More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased ...

Samsung Electronics (SEC), and GRAIL, Inc. (Nasdaq: GRAL), today announced they have signed a binding Letter of Intent for a strategic collaboration to bring GRAIL's GalleriⓇ multi-cancer early ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop Artificial Intelligence (AI) software with ...

SUTD researchers test a privacy-preserving approach that blends federated learning with cloud coordination for smart grids in ...

Cardiac imaging is evolving, and new techniques continue to uncover the secrets of the heart for cardiologists who know how ...

Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...

The global smartphone resale market is booming, worth over $55 billion annually — and Apple is leading the charge.

Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at ...

The protocol outlines standard testing methodologies of things like lumens, runtime, beam distance, and impact and water resistance, meaning that buyers can confidently compare specifications across ...

Recent studies highlight the potential of minimal residual disease (MRD) testing to influence treatment decisions in multiple myeloma and chronic lymphocytic leukemia. Testing for minimal residual ...